Your browser doesn't support javascript.
loading
Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19).
Nakagami, Hironori; Matsumoto, Tetsuya; Takazawa, Kenji; Sekino, Hisakuni; Matsuoka, Osamu; Inoue, Satoshi; Furuie, Hidetoshi; Morishita, Ryuichi.
Afiliação
  • Nakagami H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita 565-0871, Japan.
  • Matsumoto T; Department of Infectious Diseases, Graduate School of Medicine, International University of Health and Welfare, Narita Hospital, 852 Hatakeda Narita, Chiba 286-0124, Japan.
  • Takazawa K; Medical Corporation Shinanokai Shinanozaka Clinic, 20 Samon-cho, Shinjuku-ku, Tokyo 160-0017, Japan.
  • Sekino H; Sekino Clinical Pharmacology Clinic, 3-28-3 Ikebukuro, Toshima-Ku, Tokyo 171-0014, Japan.
  • Matsuoka O; Medical Corporation Heishinkai ToCROM Clinic, 4-9, Yotsuyasanei-cho, Shinjuku-ku, Tokyo 160-0008, Japan.
  • Inoue S; Medical Corporation Heishinkai OCROM Clinic, 4-12-11, Kasuga, Suita 565-0853, Japan.
  • Furuie H; Osaka Pharmacology Clinical Research Hospital, 4-1-29, Miyahara, Yodogawa-ku, Osaka 532-0003, Japan.
  • Morishita R; Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita 565-0871, Japan.
Vaccines (Basel) ; 11(10)2023 Sep 28.
Article em En | MEDLINE | ID: mdl-37896939
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article